Feedback Control of Adrenal Steroidogenesis via H2O2-Dependent, Reversible Inactivation of Peroxiredoxin III in Mitochondria by 길인섭 et al.
Molecular Cell
ArticleFeedback Control of Adrenal Steroidogenesis
via H2O2-Dependent, Reversible Inactivation
of Peroxiredoxin III in Mitochondria
In Sup Kil,1,* Se Kyoung Lee,1 Keun Woo Ryu,1 Hyun Ae Woo,1 Meng-Chun Hu,2 Soo Han Bae,1 and Sue Goo Rhee1,*
1Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Korea
2Graduate Institute of Physiology, National Taiwan University College of Medicine, Taipei 100, Taiwan, Republic of China
*Correspondence: iskil@ewha.ac.kr (I.S.K.), rheesg@ewha.ac.kr (S.G.R.)
DOI 10.1016/j.molcel.2012.05.030SUMMARY
Certain members of the peroxiredoxin (Prx) family
undergo inactivation through hyperoxidation of the
catalytic cysteine to sulfinic acid during catalysis
and are reactivated by sulfiredoxin; however, the
physiological significance of this reversible regula-
tory process is unclear. We now show that PrxIII
in mouse adrenal cortex is inactivated by H2O2
produced by cytochrome P450 enzymes during
corticosterone production stimulated by adrenocor-
ticotropic hormone. Inactivation of PrxIII triggers
a sequence of events including accumulation of
H2O2, activation of p38 mitogen-activated protein
kinase, suppression of steroidogenic acute regu-
latory protein synthesis, and inhibition of steroido-
genesis. Interestingly, levels of inactivated PrxIII,
activated p38, and sulfiredoxin display circadian
oscillations. Steroidogenic tissue-specific ablation
of sulfiredoxin in mice resulted in the persistent
accumulation of inactive PrxIII and suppression of
the adrenal circadian rhythm of corticosterone
production. The coupling of CYP11B1 activity to
PrxIII inactivation provides a feedback regulatory
mechanism for steroidogenesis that functions
independently of the hypothalamic-pituitary-adrenal
axis.
INTRODUCTION
Peroxiredoxins (Prxs) catalyze the reduction of H2O2 to water,
with a conserved cysteine residue serving as the site of oxidation
by H2O2 (Rhee and Woo, 2011). Mammalian 2-Cys Prx enzymes
(Prx I–IV), a subgroup of Prx family, are unique in that the cata-
lytic Cys undergoes hyperoxidation during catalysis to cysteine
sulfinic acid (Cys-SO2H), resulting in inactivation of peroxidase
function (Woo et al., 2003; Yang et al., 2002). Sulfinic 2-Cys
Prxs are reduced back to the active form by sulfiredoxin (Srx)
in a process that consumes ATP and cellular thiols (Biteau
et al., 2003; Chang et al., 2004). The physiological relevance of
these processes has, however, remained unknown.584 Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc.To gain insight into the role of the reversible hyperoxidation
of 2-Cys Prx under physiological conditions, we examined
various mouse tissues for the presence of sulfinic 2-Cys Prx.
PrxIII, a mitochondrion-specific enzyme, was detected in the
sulfinic form in the adrenal gland of mice maintained under
normal conditions, and sulfinic forms of other Prxs were not de-
tected (see Figure 1). The adrenal cortex is the main site for the
production of glucocorticoids (corticosterone [CS] in rodents
and cortisol in humans), which is induced by the pituitary
hormone adrenocorticotropic hormone (ACTH) in response to
stress. Psychological or physical stress induces the release
of corticotropin-releasing hormone (CRH) and arginine-
vasopressin (AVP) from the hypothalamus. CRH and AVP are
transported to the pituitary gland, where they act synergistically
to stimulate the secretion of ACTH. ACTH is then transported
to the cortex of the adrenal gland, where it rapidly stimulates
the biosynthesis and secretion of glucocorticoids. The hypo-
thalamus, pituitary gland, and adrenal gland constitute the
HPA axis, a major component of the neuroendocrine system
that controls responses to stress. The HPA axis also provides
a mechanism for feedback regulation, in which glucocorticoids
inhibit their own release by blocking the synthesis of ACTH
and CRH in the pituitary gland and hypothalamus, respectively.
Administration of the synthetic glucocorticoid dexamethasone
(DEX) thus enhances such negative feedback, resulting in
a reduction in ACTH secretion (Jefcoate, 2002; Rosol et al.,
2001).
ACTH stimulates CS synthesis predominantly through activa-
tion of cAMP signaling (Jefcoate et al., 2011; Manna et al., 2009),
although signaling pathways involving Ca2+ and MAPKs also
mediate ACTH action (Manna and Stocco, 2011). The synthesis
of CS from cholesterol requires the sequential actions of cyto-
chrome P450 (CYP) enzymes. The rate-limiting step in CS
synthesis is the transfer of cholesterol from the outer to the
inner mitochondrial membrane, where CYP11A1 catalyzes
the first side-chain cleavage reaction (Jefcoate, 2002; Rosol
et al., 2001). The last step of CS synthesis is catalyzed by
CYP11B1 in mitochondria. The cholesterol delivery to the inner
mitochondrial membrane is mediated mostly by steroidogenic
acute regulatory protein (StAR) (Miller, 2007). CS synthesis is
therefore governed predominantly by mechanisms that deter-
mine the synthesis, activation, and degradation of StAR (Jef-
coate, 2002; Stocco et al., 2005). StAR is initially synthesized
as a 37 kDa protein and is then converted to a 30 kDa form in
Figure 1. Detection of Sulfinic PrxIII and Srx
in Mouse Tissues and ACTH-Dependent
Upregulation of Srx in the Adrenal Gland
(A) Homogenates of various mouse tissues were
subjected to immunoblot analysis with antibodies
to the indicated proteins. A lysate of Y-1 cells that
had been exposed to 500 mMH2O2 for 10 min was
used as a positive control (H2O2) for sulfinic PrxI/II
and sulfinic PrxIII (rightmost lane). Two different
blot exposures are shown for PrxIII. AG, adrenal
gland; BAT, brown adipose tissue.
(B) Homogenates of whole adrenal gland (AG),
adrenal cortex, or adrenal medulla of mice were
subjected to immunoblot analysis with antibodies
to the indicated proteins. StAR and tyrosine
hydroxylase (TH) were examined as markers for
the cortex and medulla, respectively.
(C) Mice were injected with ACTH (2 or 10 mg/kg,
i.p.) or saline (0 mg/kg or Con), and at the indicated
times thereafter adrenal gland homogenates were
prepared and subjected to immunoblot analysis
of Srx (upper panel), and the relative amount of
Srx mRNA in the adrenal gland was measured by
RT and real-time PCR analysis (lower panel). The
mRNA data are means ± SD (n = 4). **p < 0.01.
(D) Six hours after injection of mice with saline
(Con) or ACTH (10 mg/kg, i.p.), the adrenal glands
were removed and subjected to immunohisto-
chemical analysis with antibodies to Srx. C, cortex;
M, medulla; ZG, zona glomerulosa; ZF, zona fas-
ciculata. Scale bars, 100 mm.
(E) Mice were exposed to immobilization (IMO)
stress for 0 or 1 hr and killed after release from
stress (SR) for the indicated times. Adrenal gland
homogenates were then subjected to immunoblot
analysis of Srx, and the relative amount of Srx
mRNA was measured by RT and real-time PCR
analysis. The mRNA data are means ± SD (n = 4).
**p < 0.01, ***p < 0.001 versus no stress.
(F) Mice were killed at the indicated times after
injection with LPS (1 mg/kg, i.p.), and adrenal
gland homogenates were subjected to immunoblot analysis of Srx. The relative amount of Srx mRNA in the adrenal gland was also determined by RT and real-
time PCR analysis as means ± SD (n = 6). *p < 0.05, **p < 0.01 versus time 0.
(G) One hour after injection of saline or dexamethasone (5 mg/kg, i.p.), mice were left undisturbed (Con), exposed to immobilization stress for 1 hr, or injected with
LPS (1 mg/kg, i.p.). The animals were killed 5 hr later, adrenal gland homogenates were subjected to immunoblot analysis of Srx, and the plasma ACTH
concentration was measured. ACTH levels are means ± SD (n = 6). **p < 0.01 for the indicated comparisons, ***p < 0.001 versus the corresponding saline value.
See also Figure S1.
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Ser194 mediated by protein kinase A (Manna et al., 2009; Miller,
2007). The precise path of cholesterol molecules into mitochon-
dria and the regulation of StAR function remain unclear, however
(Miller, 2007). The plasma CS level increases rapidly (within
several minutes) on stimulation of the adrenal cortex with
ACTH. This immediate response is dependent on cAMP, is
achieved by the action of pre-existing StAR molecules, and
does not involve new protein synthesis (Ariyoshi et al., 1998).
In addition to the acute response, CS production is also charac-
terized by a longer-term response to ACTH, which involves
maintenance of optimal levels of steroidogenic proteins
including StAR via cAMP-dependent regulation of the transcrip-
tional and translational machineries (Jefcoate et al., 2011;Manna
et al., 2009).Oxidative stress results in downregulation of steroidogenesis,
with this effect being related to a decrease in the abundance
of StAR and the activation of p38 mitogen-activated protein
kinase (MAPK) by reactive oxygen species (ROS) (Abidi et al.,
2008; Diemer et al., 2003). Steroidogenesis itself induces
oxidative stress because electron transfer by CYPs from the
donor system (NADPH, adrenodoxin reductase, and adreno-
doxin) to the substrate is not perfectly coupled and is therefore
leaky. Such leaked electrons react with O2 to produce super-
oxide and consequently H2O2, as is the case with electrons
leaked from the mitochondrial respiratory chain (Hanukoglu,
2006). About 40% of the total electron flow from NADPH
was found to be directed to ROS production during steroid
hydroxylation by CYP11B1, whereas much smaller amounts of
ROS are produced by the CYP11A1 system (Hanukoglu, 2006).Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc. 585
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thus functions as a substantial source of ROS in adrenocortical
cells.
We now show that PrxIII is the most abundant mitochondrial
antioxidant enzyme in the adrenal gland and that the seeming
imperfections of H2O2 production by CYP11B1 and reversible
inactivation of PrxIII by its own substrate represent an evolu-
tionary adaptation for feedback inhibition of steroidogenesis.
Importantly, the levels of inactivated PrxIII, activated p38, and
sulfiredoxin undergo circadian oscillations. Transgenic mice
with steroidogenic tissue-specific ablation of sulfiredoxin display
persistent accumulation of inactive PrxIII and suppression of
the adrenal circadian rhythm of corticosterone production.
RESULTS
Detection of Sulfinic PrxIII and ACTH-Dependent
Induction of Srx in the Adrenal Gland of Mice
To determine whether the sulfinic form of 2-Cys Prxs is gener-
ated under physiological conditions, we first subjected various
mouse tissue homogenates to immunoblot analysis with anti-
bodies to this form of 2-Cys Prxs (Prx-SO2). PrxI and PrxII cannot
be separated from each other by SDS-polyacrylamide gel
electrophoresis (PAGE), whereas the molecular size of PrxIII is
sufficiently larger than that of PrxI/II to allow its separation.
Sulfinic PrxIII was detected only in the adrenal gland, whereas
the sulfinic form of other 2-Cys Prxs was not detected in any of
the tissues examined (Figure 1A). PrxIII, Srx, and mitochondrial
thioredoxin (Trx2) were also most abundant in the adrenal gland,
whereas glutathione peroxidase 1 (GPx1) and PrxV, both of
which are present in mitochondria, were expressed at low levels
in the adrenal gland compared with other tissues (Figure 1A).
When the amounts of tissue homogenates analyzed were
adjusted to contain similar amounts of PrxIII, sulfinic PrxIII was
still apparent only in the adrenal gland (Figure S1A). The adrenal
gland consists of two distinct parts, the cortex and medulla,
which produce steroid hormones and catecholamines, respec-
tively. Although PrxIII was detected in both the cortex and
medulla, sulfinic PrxIII, as well as Srx, was apparent only in the
cortex (Figure 1B), suggesting that the reversible hyperoxidation
of PrxIII may play a role in CS synthesis. By comparison with
immunoblot intensities of the sulfinic form of recombinant
PrxIII, the extent of PrxIII hyperoxidation in the adrenal cortex
of mice (killed between 1000 and 1100 hr) was estimated to be
10%–20% of total PrxIII (Figure S1B). Given that hyperoxidation
of 2-Cys Prxs occurs only during the catalytic cycle (Yang et al.,
2002), these results suggested that the amount of H2O2 pro-
duced in the adrenal gland under normal physiological condi-
tions is sufficient to maintain the abundant PrxIII continuously
engaged in H2O2 reduction and that the level of mitochondrial
Srx is not enough to fully counteract the hyperoxidation of PrxIII.
The amounts of PrxIII, PrxV, and GPx1 in mitochondria of the
adrenal cortex were estimated to be 8, 0.25, and < 0.7 mg
per milligram of mitochondrial protein, respectively (Figure S1C).
Srx expression is induced in response to several biological
stimuli that elicit ROS production (Bae et al., 2009). We studied
the induction of Srx in the adrenal gland of ACTH-injected
mice. This induction of Srx protein peaked at 3–6 hr after injec-586 Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc.tion of ACTH at two different doses (2 and 10 mg/kg), with the
amount of Srx decreasing slowly thereafter (Figure 1C). The
amount of Srx mRNA was also increased by ACTH injection,
with this effect being maximal (10-fold increase) at 3 hr and
then rapidly diminishing (Figure 1C). This upregulation of Srx
occurred mainly in the zona fasciculata, rather than in the zona
glomerulosa, of the adrenal cortex (Figure 1D). Given that
ACTH is secreted during physical stress as well as in response
to lipopolysaccharide (LPS) (Rosol et al., 2001), we examined
the expression of Srx in the adrenal glands of mice that had
been exposed to immobilization stress or injected with LPS.
Srx was upregulated by immobilization stress for 1 hr, with its
abundance peaking between 2 and 5 hr after release from stress;
the amount of Srx mRNA was also increased, peaking between
0 and 2 hr after release (Figure 1E). LPS also induced Srx ex-
pression, with the abundance of both the mRNA and protein
peaking at 6 hr after stimulation (Figure 1F). Administration of
DEX before immobilization stress or LPS injection blocked the
increase in the circulating concentration of ACTH induced by
each treatment (Figure 1G). The induction of Srx by stress or
LPS was also blocked by DEX (Figure 1G), suggesting that
such induction is mediated by ACTH.
ACTH Increases the Amounts of Sulfinic PrxIII
and Phosphorylated p38 MAPK through H2O2
Produced by CYP11B1 during CS Synthesis
in the Adrenal Gland of Mice
We next monitored the production of CS and sulfinic 2-Cys Prxs
in the adrenal gland of mice injected with ACTH. The concentra-
tion of CS in plasma reached a maximum within 1 hr (the earliest
time point) and had decreased to almost the original value by 6 hr
(Figure 2A). The abundance of sulfinic PrxIII in the adrenal gland
was increased 2-fold at 1–3 hr after ACTH injection and
decreased thereafter, whereas the total amount of PrxIII did
not change (Figure 2B). These data suggested that ACTH-
induced steroidogenesis is accompanied by increased H2O2
production in mitochondria, which results in the hyperoxidation
of PrxIII and consequent accumulation of H2O2. Given that
H2O2 activates p38 MAPK in adrenal gland and hypoxic cardio-
myocytes (Abidi et al., 2008; Kulisz et al., 2002), we monitored
p38 activation by immunoblot analysis of phosphorylated
p38 (p-p38). The amount of p-p38 in the adrenal glandwasmark-
edly increased at 1–3 hr after ACTH injection, the same time
period at which the accumulation of sulfinic PrxIII was maximal
(Figure 2B). The concurrent increases in the amounts of sulfinic
PrxIII and p-p38 likely reflected overflow of H2O2 accumulated
in mitochondria into the cytosol. Although Srx expression is
upregulated by ACTH (Figures 1C and 2B), ACTH did not
substantially affect the expression of antioxidant proteins such
as PrxI to PrxVI, SOD1, SOD2, catalase, Trx1, Trx2, and GPx1
or that of steroidogenic proteins such as StAR, CYP11A1, and
CYP11B1 in the adrenal gland, with only heme oxygenase-1
(HO-1) showing increased expression at 6 hr after ACTH
injection (Figure S2A).
In the experiments with ACTH-injected mice, saline was in-
jected as a control. A saline injection by itself, however, will
inevitably induce stress and stimulate the production of ACTH
and CS, thereby affecting the levels of PrxIII-SO2, p-p38, and
Figure 2. Effects of ACTH on the Levels of PrxIII-
SO2, p-p38 MAPK, and Srx in the Adrenal Gland
(A and B) Mice were injected intraperitoneally (i.p.) with
ACTH (10 mg/kg) and killed at the indicated times there-
after. Plasma CS levels (means ± SD, n = 10 to 12) were
measured (A), and adrenal gland homogenates were
prepared and subjected to immunoblot analysis (B).
(C–F) Mice were injected with saline () or metyrapone
(Mety; 100 mg/kg, i.p.) and 1 hr later were injected with
saline or ACTH (10 mg/kg, i.p.). The animals were killed 3 hr
after ACTH administration, adrenal gland homogenates
were subjected to immunoblot analysis (C), and the
plasma levels of CS (D), progesterone (E), and ACTH (F)
were measured. Data are means ± SD (n = 4). *p < 0.05,
**p < 0.01, ***p < 0.001.
(G) Mouse adrenal glands were incubated in the absence
(Con) or presence of 200 mM BHA for 1 hr and then in the
additional absence or presence of 500 nM ACTH for 3 hr,
after which adrenal gland homogenates were subjected to
immunoblot analysis.
(H) Three fresh bovine adrenal glands were obtained from
a local slaughterhouse and sliced to isolate the cortex. The
cortical slices were incubated in the absence (Con) or
presence of 500 nM ACTH (n = 3 each) for 3 hr at 37C,
after which the tissue was homogenized and subjected to
immunoblot analysis. See also Figure S2.
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injected mice with DEX to suppress the synthesis of ACTH and
CRH before the injection of saline or ACTH. The levels of CS
and PrxIII-SO2 in mice injected with saline alone were clearly
higher than those inmice injectedwith saline after DEX treatment
(Figure S2B). The abundance of Srx and p-p38 also appeared to
be slightly decreased when mice were treated with DEX prior to
saline injection. However, the extent of these effects of DEX,
especially those on the levels of Srx, PrxIII-SO2, and p-p38
MAPK, were relatively small compared with those induced by
ACTH (Figure S2B). Placebo injections were therefore routinely
performed without prior DEX treatment.
The ACTH-induced increases in the amounts of both sulfinic
PrxIII and p-p38 in the adrenal gland were prevented by prior
treatment of mice with the CYP11B1 inhibitor metyrapone
(Figure 2C). Metyrapone also blocked basal as well as ACTH-
induced CS production (Figure 2D), whereas progesterone
production, which depends on CYP11A1 but not on CYP11B1,
was slightly increased by metyrapone treatment (Figure 2E),
suggesting that CYP11A1 activity was not inhibited by metyra-
pone. The plasma ACTH level was increased in mice injected
with metyrapone, likely due to decreased feedback inhibition
of ACTH secretion by CS (Figure 2F). The levels of CYP11A1
and CYP11B1 in the adrenal gland were not affected by either
ACTH or metyrapone (Figure 2C). These results are consistent
with previous data showing that CYP11B1 is the main source
of H2O2 production during steroidogenesis in the adrenal gland
(Hanukoglu, 2006), and they suggested that H2O2 produced
by CYP11B1 is required for hyperoxidation of PrxIII and forphosphorylation of p38. A role for H2O2 in p38 activation was
also shown by the observation that prior incubation of the
adrenal gland in vitro with the antioxidant butylated hydroxyani-
sole (BHA) inhibited ACTH-induced p38 phosphorylation
(Figure 2G).
The principal glucocorticoid in nonrodent mammals is cortisol,
whose synthesis, like that of CS, is also mediated by CYP11A1
and CYP11B1. Stimulation of bovine adrenal glands with ACTH
also resulted in PrxIII hyperoxidation, p38 phosphorylation, and
Srx induction (Figure 2H).
p38 MAPK Negatively Regulates ACTH-Induced
Steroidogenesis by Inhibiting StAR Synthesis
Although the underlying mechanism is not known, activation of
p38 MAPK is associated with downregulation of both StAR
activity and steroid synthesis in Leydig cells (Diemer et al.,
2003). To examine the effect of p38 activation on CS synthesis
in the adrenal gland, we incubated the mouse adrenal gland in
medium containing the p38 inhibitor SB202190 before stimula-
tion with ACTH. ACTH-induced CS production was increased
by 50% by prior exposure of the adrenal gland to SB202190
(Figure 3A). The basal level of CS production was also enhanced
by the p38 inhibitor. In addition, SB202190 potentiated the
ACTH-induced hyperoxidation of PrxIII, as would be expected
from the increased H2O2 production accompanying CS
synthesis (Figure 3B). However, neither ACTH nor SB202190
had a measurable effect on the amount of StAR protein
(Figure 3B). Regulation of StAR activity is a complex process
that involves multiple signaling pathways that coordinate theMolecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc. 587
Figure 3. Relation between p38 MAPK Activity and StAR Expression
(A and B) Mouse adrenal glands were incubated in the absence or presence of
10 mM SB202190 (SB) for 1 hr and then in the additional absence or presence
of 500 nM ACTH for the indicated times, after which the concentration of CS
in the medium was measured (A). Immediately after the last time point for CS
measurement in (A), adrenal gland homogenates were prepared and subjected
to immunoblot analysis with antibodies to the indicated proteins (B). CS data
are means ± SD (n = 6). *p < 0.05, **p < 0.01 versus control (None).
(C) Mouse adrenal glands were incubated with or without cycloheximide (CHX,
0.1 mg/ml) or 10 mMSB202190 (SB) for 1 hr and then in the additional absence
or presence of 500 nM ACTH for 1 hr. Adrenal gland homogenates were then
subjected to immunoblot analysis of StAR and p-StAR, and the concentration
of CS in the culture medium was measured. CS values are means ± SD (n = 6).
*p < 0.05, **p < 0.01.
(D) Adrenal gland homogenates prepared from wild-type (p38aWT) and
p38aDSC mice were subjected to immunoblot analysis with antibodies to the
indicated proteins.
(E) Plasma concentrations of CS and ACTH in p38aWT and p38aDSCmice. Data
are means ± SD (n = 8). **p < 0.01. See also Figure S3.
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posttranslational mechanisms (Manna et al., 2009). It is generally
accepted, however, that cholesterol delivery depends largely on
StAR molecules that are newly synthesized and phosphorylated
at Ser194 (Artemenko et al., 2001). Consistent with this notion,
the amount of phosphorylated StAR (p-StAR) was increased in
adrenal glands treated with ACTH and SB202190 (Figure 3B),
and the protein synthesis inhibitor cycloheximide completely
blocked CS production and phosphorylation of StAR induced
by ACTH in the absence or presence of SB202190 (Figure 3C).
However, none of these agents affected StAR abundance
(Figure 3C), likely because the amount of newly synthesized
StAR is much smaller than that of the inactive protein present
within mitochondria of the adrenal gland.588 Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc.The effects of SB202190 on StAR expression and steroido-
genesis were also evaluated in Y-1 adrenocortical cells, which
express only a low level of StAR and produce progesterone in
response to intracellular cAMP accumulation. Treatment of the
cells with SB202190, forskolin (an activator of adenylyl cyclase),
or both agents increased the amount of StAR (Figure S2A). The
same treatments also increased the production of progesterone
by the cells, and the extent of steroid production appeared to
correlate with the amount of StAR in the cells, with the effect of
SB202190 plus forskolin being the largest (Figure S2A). These
results suggested that, like the cAMP signaling pathway, the
p38 signaling pathway regulates steroidogenesis by modulating
the abundance of StAR. When Y-1 cells were supplied with
22R-hydroxycholesterol, which is able to permeate the inner
mitochondrial membrane independently of StAR, treatment
with SB202190 increased StAR abundance but did not affect
progesterone production (Figure S2A). SB202190 also did not
increase StAR levels in Y-1 cells in the presence of cyclohexi-
mide (Figure S2B), suggesting that p38 inhibits new StAR
synthesis.
Among the four p38 isoforms (a, b, g, and d), SB202190
selectively inhibits the a and b isoforms, and p38a is highly ex-
pressed in adrenocortical cells (Abidi et al., 2008; Kulisz et al.,
2002). To further study the role of p38 in StAR synthesis, we
generated a mouse model (p38aDSC) in which p38a is ablated
specifically in steroidogenic tissues. Expression of p38 was
not detected in the adrenal gland of p38aDSC mice but was
unaffected in the liver (Figure S2C). The ablation of p38 had
no effect on the abundance of StAR protein, CYP11A1, and
CYP11B1, but markedly increased the level of p-StAR (Fig-
ure 3D), supporting the notion that p38 negatively regulates
new StAR synthesis. Plasma CS levels were increased by
40% in p38aDSC mice compared with those in p38aWT mice,
whereas the circulating ACTH concentration was reduced by
30% in p38aDSC mice (Figure 3E). This decreased ACTH
level was likely due to increased feedback inhibition of ACTH
secretion by CS. Ablation of p38a resulted in only a moderate
increase in the plasma CS level, probably because of a
continued contribution of other p38 isoforms or unknown com-
pensatory mechanisms.
Ablation of Srx Induces Suppression of Steroidogenesis
and Accumulation of Cholesterol in the Adrenal Gland
To gain further insight into the role of Srx in steroidogenesis, we
generated a mouse model (SrxDSC) in which Srx is ablated
specifically in steroidogenic tissues (Figures S4A and S4B).
The amounts of Srx mRNA (Figure S4C) and protein (Figure S4D)
in the adrenal gland of SrxDSC mice were 10% of those in the
adrenal gland of wild-type (SrxWT) mice, whereas the abundance
of Srx protein was unaffected in the brain and was actually
increased in brown adipose tissue of the mutant animals (Fig-
ure S4D). The reduced abundance of Srx in the zona fasciculata
of the adrenal gland of SrxDSC mice was also confirmed by
immunohistochemical analysis (Figure S4E).
Plasma CS levels were reduced significantly in SrxDSC mice
compared with those in SrxWT mice, whereas the circulating
ACTH concentration was increased by 80% in SrxDSC mice
(Figure 4A). The plasma level of norepinephrine was not affected
Figure 4. Effects of Steroidogenic Tissue-
Specific Deletion of Srx on CS Production
and the Levels of Sulfinic PrxIII and StAR in
the Mouse Adrenal Gland
(A) CS and ACTH levels in plasma of SrxWT
and SrxDSC mice. Data are means ± SD (n = 12).
**p < 0.01.
(B and C) Adrenal gland homogenates prepared
from SrxWT and SrxDSC mice were subjected to
immunoblot analysis with antibodies to the indi-
cated proteins (B). Immunoblot intensities of
StAR relative to those of b-actin were also deter-
mined (C); data are means ± SD (n = 6). **p < 0.01.
(D) SrxWT and SrxDSC mice were injected with
dexamethasone (DEX; 2 mg/kg, i.p.) or vehicle ().
At 6 hr after injection, adrenal glands from themice
were subjected to immunoblot analysis with anti-
bodies to the indicated proteins.
(E and F) SrxWT and SrxDSC mice were injected
twice a day for 5 days with vehicle ( or Con) or
SB202190 (SB; 0.2 mg/kg, i.p.). At 3 hr after the
last injection, adrenal glands from the mice were
subjected to immunoblot analysis with antibodies
to the indicated proteins (E) and CS levels in
plasma were determined (F). CS data are means ±
SD (n = 6). *p < 0.05.
(G) Oil red O staining of adrenal glands of SrxWT
and SrxDSC mice. Scale bars, 100 mm. See also
Figure S4.
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adrenal medulla was not impaired by Srx ablation. Immunoblot
analysis revealed that ablation of Srx resulted in a marked
increase in the abundance of sulfinic PrxIII as well as an 40%
decrease in that of StAR and a similar decrease in that of
p-StAR in the adrenal gland (Figures 4B and 4C). The amounts
of PrxI to PrxIII, CYP11A1, and CYP11B1 in the adrenal gland
did not differ substantially between SrxWT and SrxDSC mice (Fig-
ure 4B). These results suggested that the reduced plasma CS
level of SrxDSC mice is due mostly to downregulation of StAR
protein rather than to that of other steroidogenic proteins.
Administration of DEX for 6 hr reduced sulfinic PrxIII and StAR
in the adrenal gland of SrxDSC as well as SrxWT mice (Figure 4D),
indicating that PrxIII hyperoxidation in SrxDSC mice is also medi-
ated by H2O2 generated by ACTH-dependent CS synthesis and
that the expression and maintenance of StAR in SrxDSC mice are
dependent on signaling by ACTH as they are in SrxWT mice. The
abundance of StAR and p-StAR in the adrenal gland as well as
the plasma concentration of CS in SrxDSC mice increased to
levels similar to those in SrxWT mice in response to injection
with SB202190 twice a day for 5 days, whereas the amounts of
StAR and p-StAR in the adrenal gland of SrxWT mice were also
increased slightly by the same treatment (Figures 4E and 4F).
These data suggested that the downregulation of StAR apparent
in SrxDSC mice is attributable to p38 activation induced by theMolecular Cell 46, 584–constitutively increased H2O2 levels that
result from the inability to reactivate
sulfinic PrxIII.
StAR deficiency gives rise to congenital
adrenal hyperplasia, in which steroido-genesis is greatly impaired, resulting in cholesterol accumula-
tion in steroidogenic cells (Hasegawa et al., 2000). Histological
analysis with oil red O showed that the number and size of
vacuoles associated with neutral lipids were increased in the
adrenal gland of SrxDSC mice compared with that of SrxWT
mice (Figure 4G). In addition, analysis of adrenal gland lipid
extracts indicated that the amount of cholesterol esters,
a storage form of cholesterol, was increased by 50% in the
adrenal gland of SrxDSC mice (Figure S4G). Microarray analysis
also revealed a total of 29 genes whose expression level was
increased at least 1.7-fold in the adrenal gland of SrxDSC mice
relative to SrxWT mice (data not shown). Among these genes,
those for Cidea, Fsp27, and peroxisome proliferator-activated
receptor g (PPARg) are related to the formation of lipid droplets
(Nishino et al., 2008). RT and real-time PCR analysis confirmed
that the abundance of Cidea, Fsp27, and PPARg mRNAs
was increased 2- to 3-fold in the adrenal gland of SrxDSC mice
(Figure S4H).
The levels of CS, sulfinic PrxIII, and p-p38 in SrxWT and SrxDSC
mice were compared after injection with ACTH. The increase in
the plasma CS concentration in response to ACTH injection
was smaller in SrxDSC mice than in SrxWT mice (Figure 5A).
Consistent with the results shown in Figure 2B, the administra-
tion of ACTH to SrxWT mice resulted in an increase in the amount
of sulfinic PrxIII in the adrenal gland that peaked at 3 hr and594, June 8, 2012 ª2012 Elsevier Inc. 589
Figure 5. Effects of Steroidogenic Tissue-Specific
Srx Ablation on CS Production and the Levels of
Sulfinic PrxIII and p-p38MAPK in the Adrenal Gland
of Mice Injected with ACTH
(A) Time course of plasma CS concentration in SrxWT and
SrxDSC mice injected with ACTH (10 mg/kg, i.p.). Data are
means ± SD (n = 6). *p < 0.05 versus corresponding value
for SrxWT.
(B–D) Adrenal gland homogenates prepared from SrxWT
and SrxDSC mice at the indicated times after injection of
ACTH were subjected to immunoblot analysis (B). The
intensities of sulfinic PrxIII bands relative to those of total
PrxIII bands (C), and the intensities of sulfinic PrxIII bands
relative to those of total p38 bands (D) were estimated from
immunoblots similar to those in (B). Data are means ± SD
(n = 4). HO-1, heme oxygenase-1. See also Figure S5.
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dance of p-p38 that also peaked at 3 hr but diminished more
rapidly (Figure 5B). As expected, the amount of sulfinic PrxIII in
the adrenal gland of ACTH-injected SrxDSC mice increased to
levels that were much higher than those apparent in SrxWT
mice and remained elevated (Figures 5B and 5C). The abun-
dance of p-p38 in the adrenal gland of ACTH-stimulated SrxDSC
mice also peaked at 3 hr, but achieved levels that were much
higher than those apparent in SrxWT mice; the amount of p-p38
decreased rapidly thereafter, but remained higher than that in
SrxWT mice (Figures 5B and 5D). The finding that the amounts
of sulfinic PrxIII and p-p38 increase concurrently in SrxDSC
mice as well as in SrxWT mice supported the notion that the
accumulation of mitochondrial H2O2 as a result of PrxIII inacti-
vation is responsible for p38 phosphorylation. However, the
observation that the level of p-p38 decreased rapidly after
achieving its ACTH-induced peak in SrxDSC mice, even though
the amount of sulfinic PrxIII remained high, suggested that
dephosphorylation of p-p38 is determined by factors other
than the mitochondrial release of H2O2.
The amounts of CS produced by adrenal glands of SrxDSC
mice in vitro in the absence or presence of ACTH were also
smaller than those produced by adrenal glands of SrxWT mice
(Figure S5A). As observed with adrenal glands from ACTH-
injected mice (Figure 5B), the levels of sulfinic PrxIII and p-p38
in adrenal glands stimulated with ACTH in vitro were greater
for SrxDSC mice than for SrxWT mice (Figure S5B).590 Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc.Circadian Variation in Sulfinic PrxIII,
p-p38 MAPK, StAR, and Srx Abundance
in the Adrenal Gland
The levels of ACTH and CS show a daily oscilla-
tion, with a peak around the onset of night, in
rodents (Oster et al., 2006; Son et al., 2008).
We measured the circadian changes in plasma
CS concentration at 3 hr intervals during a
12 hr light, 12 hr dark cycle (light on from 0600
to 1800 hr) in SrxWT and SrxDSCmice. Consistent
with previous observations, plasma CS levels of
SrxWT mice exhibited circadian oscillation
during the light-dark cycle (Figure 6A). Immuno-
blot analysis revealed that the amounts ofsulfinic PrxIII, p-p38 MAPK, StAR, and Srx in the adrenal gland
of SrxWT mice also showed daily variation, whereas there were
no changes in the amounts of PrxIII or p38 (Figures 6B and
S6A). The amount of sulfinic PrxIII increased after CS production
had peaked, that of p-p38 increased in parallel with the accu-
mulation of sulfinic PrxIII, and that of StAR began to decrease
as p-p38 increased. These results are consistent with the notion
that H2O2 produced during CS synthesis results in the gradual
accumulation of sulfinic PrxIII, which in turn leads to further
accumulation of H2O2 and consequent phosphorylation of p38,
which then results in inhibition of nascent StAR production
and consequently in that of CS production.
Ablation of Srx resulted in a decrease in plasma CS levels at
all time points (Figure 6A). However, although the amplitude
was much reduced, the phase of the daily oscillation in CS levels
remained unchanged. The abundance of sulfinic PrxIII in the
adrenal gland of SrxDSC mice wasmuch higher than that in SrxWT
mice, and it showed no circadian variation (Figure 6B). As
expected from the increased abundance of sulfinic PrxIII (and
the consequent increased levels of H2O2), the abundance of
p-p38 was higher and that of StAR was lower in the adrenal
gland of SrxDSC mice than in SrxWT mice (Figures 6B and S6A).
Like the plasma level of CS, the amounts of both p-p38 and
StAR in the adrenal gland showed circadian variation, but with
a much reduced amplitude in SrxDSC mice (Figures 6B and
S6A). These results suggested that PrxIII hyperoxidation is
linked not only to the synthesis of CS but also to its circadian
Figure 6. Circadian Variation in Plasma CS as well as Adrenal Sul-
finic PrxIII, p-p38 MAPK, StAR, and Srx Levels of SrxWT and SrxDSC
Mice
(A) Plasma CS levels in SrxWT and SrxDSC mice were measured at 3 hr intervals
during a 12 hr light, 12 hr dark cycle. Data are means ± SD (n = 6). *p < 0.05,
**p < 0.01 versus SrxWT mice.
(B) The adrenal glands of mice studied in (A) were subjected to immunoblot
analysis with antibodies to sulfinic Prx, to PrxIII, to p-p38 MAPK, to p38, to
StAR, to Srx, and to b-actin. The intensities of sulfinic PrxIII and p-p38 bands
relative to those of total PrxIII and total p38 bands, respectively, were esti-
mated from immunoblots similar to those in Figure S6. The blot intensities of
StAR and Srx were normalized by those of b-actin. Data are means ± SD from
six immunoblots (two blots each for three mice of each genotype). See also
Figure S6.
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given that CS production as well as the amounts of p-p38 and
StAR still undergo daily variation, albeit with a much reduced
amplitude, in the absence of changes in the amount of sulfinic
PrxIII in the adrenal gland of SrxDSC mice, factors other than
PrxIII hyperoxidation also likely contribute to the circadian varia-
tion of CS, p-p38, and StAR.
DISCUSSION
The oxidative inactivation of 2-Cys Prxs has been speculated to
be an evolutionary adaptation that allows H2O2 to accumulate
for a signaling function (Wood et al., 2003). However, sulfinic
Prx and the protective effect of Srx have been observed only in
cells or tissues exposed to damaging levels of oxidative stress
(Bae et al., 2009; Planson et al., 2011). We have now found
that 10%–20% of PrxIII exists in the sulfinic form in the mouse
adrenal cortex, whereas this form of PrxIII was not detected
in other tissues of mice maintained under normal laboratoryconditions. The abundance of sulfinic PrxIII in the adrenal gland
increased in response to ACTH stimulation as a result of H2O2
produced mostly by CYP11B1 during CS synthesis. Given that
Prx molecules undergo hyperoxidation only when engaged in
the catalytic cycle, the extent of PrxIII hyperoxidation is
a measure of how much H2O2 is removed by PrxIII (Rhee and
Woo, 2011). The accumulation of inactive PrxIII would thus be
expected to result in the buildup of H2O2 in mitochondria and
its overflow into the cytosol.
Various approaches adopted in the present study indicate that
such a buildup of mitochondrial H2O2 results in the activation of
p38 MAPK. An increase in the abundance of sulfinic PrxIII in
the adrenal gland was thus always accompanied by a concomi-
tant increase in that of p-p38. Hydrogen peroxide mediates
the activation of p38 and JNK by activating ASK1, an upstream
kinase of these two stress-activated MAPKs (Matsuzawa and
Ichijo, 2008). The inhibition of p38 was previously shown to
result in activation of progesterone synthesis, likely through
stimulation of StAR expression (Diemer et al., 2003). We found
that inhibition of p38 enhanced ACTH-induced CS production,
but neither ACTH nor a p38 inhibitor had a measurable effect
on StAR abundance in the adrenal gland. Only after depletion
of pre-existing StAR protein by exposure of mice to DEX was
such an effect of ACTH and p38 inhibition apparent. This is
because whereas CS production depends on newly synthesized
StAR, steroidogenic cells often contain a large fraction of inac-
tive, intramitochondrial StAR that interferes with detection of
the newly synthesized protein (Artemenko et al., 2001; Stocco
et al., 2005). During the circadian cycle, however, oscillation of
StAR was apparent in the adrenal gland without depletion of
inactive StAR, probably because the intramitochondrial pro-
tein was actively degraded during the cycle. Furthermore, the
increase in the abundance of StAR resulting from p38 inhibition
was readily apparent in Y-1 cells, which contain only a small
amount of the inactive protein.
StAR regulation has been revealed to be a complex process
that is mediated at multiple levels, including the well-estab-
lished cAMP-dependent transcriptional machinery, posttran-
scriptional processing and translation of StAR mRNA, and
posttranslational modification (Manna et al., 2009). The phos-
phorylation of StAR on Ser194 by protein kinase A is thought
to be required to render the newly synthesized protein fully
active with regard to its capacity to support cholesterol trans-
port (Artemenko et al., 2001). In the present study, ACTH and
the p38 inhibitor did not substantially affect the level of StAR
mRNA in the adrenal gland (data not shown), but they
increased the abundance of phosphorylated (newly synthe-
sized) StAR. The reciprocal relationship between p38 and
p-StAR could be also seen in the adrenal gland of p38aDSC.
We showed that stress signals (ACTH, immobilization, and
LPS) induce Srx expression at both the mRNA and protein
levels. It has been shown that expression of Srx is upregulated
via activator protein-1 (AP-1) or nuclear factor erythroid 2-
related factor 2 (Nrf2) (Bae et al., 2009) and that ACTH induces
transcriptional activity of AP-1(Beuschlein et al., 2001). It
appears that on stimulation of ACTH receptor, Srx is produced
via a cAMP-AP-1 pathway (unpublished data) and then trans-
locates into mitochondria in response to oxidative stressMolecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc. 591
Figure 7. Model for the Role of CYP-Generated H2O2, Reversible
Hyperoxidation of PrxIII, and Induction of Srx in ACTH-Induced
Steroidogenesis in the Adrenal Cortex
The steps leading to CS synthesis are indicated by black arrows, the steps
leading to H2O2 accumulation and feedback inhibition of StAR synthesis are
indicated by red arrows, and the steps leading to a decrease in the concen-
tration of H2O2 to basal levels are indicated by blue arrows. See Discussion
for details.
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ablated Srx specifically in steroidogenic tissues of mice. Such
Srx ablation (90%) resulted in upregulation of the amount
of sulfinic PrxIII in the adrenal gland compared with that in
wild-type mice. This increased PrxIII inactivation resulted in
increased levels of H2O2 and consequent activation of p38 as
well as in downregulation of the synthesis and phosphorylation
of StAR. CS synthesis was thus much reduced in Srx-deficient
mice compared with that in wild-type mice. As a result of the
downregulation of CS synthesis in Srx-deficient mice, deposi-
tion of cholesterol esters was markedly increased in the adrenal
gland.
The daily oscillation of CS is driven via the HPA axis under
the control of the master circadian clock, which resides in the
suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN
thus activates the rhythmic release of CRH from the hypothal-
amus, which evokes circadian ACTH release from the pituitary
gland, which in turn regulates the circadian release of CS from
the adrenal cortex (Oster et al., 2006). In addition, the SCN clock
signal can be transmitted to the adrenal cortex through sympa-
thetic neurons that innervate the adrenal medulla. As the output
of the HPA axis, CS is secreted in discrete ultradian pulses, with
a period of 1 hr in the rat (Lightman et al., 2008). In addition to
the master clock, the adrenal peripheral clock controls the
synthesis of StAR independently of the ACTH circadian rhythm
in mice, and the changes in StAR correlate with those in the592 Molecular Cell 46, 584–594, June 8, 2012 ª2012 Elsevier Inc.CS level in blood (Son et al., 2008). In the present study, we
observed circadian rhythms of Srx, sulfinic PrxIII, and p-p38 in
the adrenal gland, whereas the total amounts of p38 and PrxIII
remained unchanged. The opposite oscillations of CS and sul-
finic PrxIII, the parallel oscillations of sulfinic PrxIII and p-p38,
and the opposite oscillations of p-p38 and StAR observed
during the circadian cycle support the link between CS
synthesis, hyperoxidation of PrxIII, phosphorylation of p38, and
synthesis of StAR. These daily fluctuations are likely important
aspects of the peripheral clock specific to the adrenal gland.
Ablation of Srx resulted in a decrease in plasma CS levels at all
time points during the circadian cycle. In SrxDSC mice, oscillation
of sulfinic PrxIII was no longer apparent, whereas CS, p-p38, and
StAR continued to oscillate, but with much reduced amplitudes.
These results suggest that PrxIII hyperoxidation is linked not only
to the synthesis but also to the circadian variation of CS via the
H2O2-p38-StAR pathway. They also suggest that factors other
than PrxIII hyperoxidation contribute to the circadian variation
of CS, p-p38, and StAR.
On the basis of our findings, we propose amodel for themech-
anism underlying the feedback regulation of ACTH-induced
steroidogenesis via PrxIII hyperoxidation (Figure 7). Binding of
ACTH to its receptor triggers the cAMP-PKA signaling pathway,
which results in the rapid phosphorylation and consequent
activation of StAR, which mediates the delivery of cholesterol
from the outer mitochondrial membrane to CYP11A1 located
on the matrix side of the inner mitochondrial membrane.
CYP11A1 catalyzes the oxidative cleavage of the cholesterol
side chain to produce pregnenolone, which is then converted
to progesterone (not shown in Figure 7) by 3b-HSD and then to
11-deoxycorticosterone by CYP21 in the endoplasmic retic-
ulum. CS synthesis is completed at the inner mitochondrial
membrane, where CYP11B1 catalyzes the hydroxylation of
11-deoxycorticosterone. In a later stage of ACTH stimulation,
the synthesis of steroidogenic proteins including StAR and
CYPs is increased in a manner dependent largely on cAMP-
PKA signaling in order to meet the increased demand for CS
(or to maintain their optimal levels).
The oxidation reactions catalyzed by CYP11A1 and CYP11B1
require donation of electrons from NADPH through the interme-
diary of mitochondrial AdxR and Adx, which are located on the
matrix side of the inner mitochondrial membrane. The process
of electron transfer, especially that involving CYP11B1, leaks
a large portion (40% for CYP11B1) of the total electron flow
fromNADPH, resulting in reduction of O2 to the superoxide anion
(O2
$), which is rapidly converted to H2O2 by SOD2. Leakage by
the CYP11B1 system increases in the presence of its substrate,
11-deoxycorticosterone. CS production is thus accompanied
by generation of H2O2. PrxIII is by far the most important
H2O2-eliminating enzyme in mitochondria of the adrenal cortex.
In the H2O2-elimination reaction, two reduced PrxIII subunits
(PrxIII-SH) are converted to a disulfide-linked dimer (PrxIII-S-S-
PrxIII), which is then reduced back to PrxIII-SH by Trx2. During
catalysis, PrxIII is occasionally but inevitably hyperoxidized to
sulfinic PrxIII (PrxIII-SO2) and becomes inactivated. This hyper-
oxidation is reversed by Srx. The fraction of PrxIII molecules
that undergo hyperoxidation is low, but proportional to the
number of H2O2 molecules reduced by the enzyme. In the early
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increase substantially above the basal level because the activity
of Srx in mitochondria is sufficient to counteract the low level of
hyperoxidation. At a later stage of such stimulation, when CS
synthesis is increased, H2O2 production also increases and is
followed by an increase in the level of PrxIII hyperoxidation.
The capacity of Srx in mitochondria is now no longer sufficient
to counteract this increased hyperoxidation, resulting in the
accumulation of inactive PrxIII and the consequent buildup of
H2O2 in mitochondria and its overflow into the cytosol, where it
triggers the phosphorylation of p38 by activating ASK1 and
prolongs the lifetime of the phosphorylated state by inactivating
dual-specificity phosphatase (DSP). Phosphorylated (activated)
p38 inhibits StAR synthesis through an unknown mechanism,
resulting in downregulation of the production of CS.
Independently of the H2O2 buildup, Srx is synthesized likely
as a downstream response to cAMP signaling. In addition, in
response to the oxidative stress in mitochondria, Srx translo-
cates into these organelles to catalyze the reduction of PrxIII-
SO2 to active PrxIII-SH, which in turn lowers the level of H2O2
to that existing before ACTH stimulation. The timing of Srx
translocation relative to that of sulfinic PrxIII accumulation is
not clear.
It has been puzzling both why Prxs are inactivated via hyper-
oxidation of the active site cysteine by their own substrate
(H2O2) and are reactivated via an ATP-consuming process
catalyzed by Srx, as well as why certain CYPs like CYP11B1
waste reducing equivalents and thereby generate toxic oxidants.
Our results now indicate that the leakiness of CYP11B1 does not
represent a metabolic imperfection, but rather that it evolved
together with reversible PrxIII hyperoxidation in order to serve
a useful purpose. The extent of PrxIII hyperoxidation is pro-
portional to the number of H2O2 molecules removed by PrxIII,
which in turn is proportional to the number of CS molecules
synthesized. The accumulation of H2O2 resulting from the
buildup of sulfinic PrxIII thus signals that a sufficient amount of
CS has been synthesized. The seeming imperfections of CYP
leakiness and Prx hyperoxidation together thus provide a nega-
tive feedback mechanism that functions independently of the
HPA axis. Given that both the accumulation of hyperoxidized
PrxIII and its reduction by Srx are relatively slow, this feedback
mechanism may not be consequential in the initial acute phase
of CS release or in the pulsatile ultradian release of CS in
response to stress, but our data suggest that it is critical for
the circadian rhythm of CS production.EXPERIMENTAL PROCEDURES
Antibodies and Reagents
Rabbit antisera specific for PrxI–VI, for hyperoxidized 2-Cys Prx, or for Srx
were described previously (Chang et al., 2004; Woo et al., 2003). Antibodies
to StAR, to CYP11B1, to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), or to total p38MAPKwere obtained from Santa Cruz Biotechnology;
those to CYP11A1 or to tyrosine hydroxylase were from Millipore; those to
GPx1, to catalase, to SOD1, to SOD2, to Trx1, or to Trx2 were from Young
In Frontier; those to p38 MAPK phosphorylated on Thr180 and Tyr182 were
from Cell Signaling; and those to HO-1 were from Stressgen. Antibodies to
b-actin as well as ACTH (1–24), forskolin, metyrapone, LPS, BHA, and DEX
were obtained from Sigma. SB202190 were obtained from Calbiochem.Rabbit antibodies to StAR phosphorylated at Ser194 were prepared as
described (Jo et al., 2005) and subjected to affinity purification with the use
of Sepharose 4B resin (GE Healthcare) conjugated with the corresponding
nonphosphorylated form of the antigenic phosphopeptide.
Animals
Male C57BL/6J mice were obtained from the Jackson Laboratory. Conditional
Srx KO (SrxDSC) mice were obtained by crossing mice with a floxed Srx allele
with Scc-iCre mice (Figure S4, Supplemental Experimental Procedures). All
mice were housed in a temperature-controlled room with a 12 hr light, 12 hr
dark cycle, and all experiments were performed with age-matched male
mice between 2 and 3 months of age. A week before sacrifice, animals were
housed individually. For exposure to immobilization stress, mice were placed
in a 50 ml conical tube with the bottom removed. All animal experiments were
performed according to protocols approved by the Institutional Animal Care
and Use Committee of Ewha Woman’s University.
Assay of CS, Progesterone, and ACTH
Plasma was isolated frommouse blood and immediately frozen at80C until
assay. The concentrations of CS, progesterone, and ACTH in plasma or in
culture medium were determined with the use of enzyme-linked immunosor-
bent assay kits (DRG Diagnostics).
Other Methods
Mitochondria were isolated with the use of a mitochondrial isolation kit
(Pierce). Adrenal gland and cell culture are described in Supplemental
Experimental Procedures.
Statistical Analysis
Quantitative data are presented as means ± SD and were analyzed with
Student’s t test. A p value of < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.molcel.2012.05.030.
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